VTR · Ventas, Inc. · Executive Compensation
$87.98
-0.90 (-1.01%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$47.00B
Shares
528.82M
Volume · Nov 17
171.06K
Avg daily vol (3M)
3.6M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman and Chief Executive Officer | $17,501,073 |
| Robert Probst | Executive Vice President and Chief Financial Officer | $6,462,221 |
| J. Justin Hutchens | Executive Vice President, Senior Housing and Chief Investment Officer | $6,349,630 |
| Carey S. Roberts | Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary | $4,189,849 |
| Peter Bulgarelli | Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. | $4,180,627 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman and Chief Executive Officer | $14,438,118 |
| Robert Probst | Executive Vice President and Chief Financial Officer | $5,194,905 |
| J. Justin Hutchens | Executive Vice President, Senior Housing and Chief Investment Officer | $4,777,522 |
| Peter Bulgarelli | Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. | $3,706,817 |
| Carey S. Roberts | Executive Vice President, General Counsel and Ethics & Compliance Officer | $3,630,060 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman and Chief Executive Officer | $13,520,625 |
| Robert Probst | Executive Vice President and Chief Financial Officer | $4,923,925 |
| J. Justin Hutchens | Executive Vice President, Senior Housing and Chief Investment Officer | $4,392,551 |
| Peter Bulgarelli | Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. | $3,623,314 |
| Carey S. Roberts | Executive Vice President, General Counsel and Ethics & Compliance Officer | $3,490,371 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman and Chief Executive Officer | $14,059,092 |
| Robert Probst | Executive Vice President and Chief Financial Officer | $4,943,506 |
| John D. Cobb | EVP and Chief Investment Officer | $4,790,817 |
| Peter Bulgarelli | Executive Vice President, Outpatient Medical and Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. | $3,591,079 |
| J. Justin Hutchens | Executive Vice President, Senior Housing and Chief Investment Officer | $3,573,610 |
| Carey S. Roberts | Executive Vice President, General Counsel and Ethics & Compliance Officer | $3,351,339 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman and Chief Executive Officer | $14,263,728 |
| Robert Probst | Executive Vice President and Chief Financial Officer | $7,345,066 |
| John D. Cobb | EVP and Chief Investment Officer | $7,259,949 |
| Peter Bulgarelli | Executive Vice President, Outpatient Medical & Research, Ventas, Inc. President and CEO, Lillibridge Healthcare Services, Inc. | $5,111,458 |
| J. Justin Hutchens | Executive Vice President, Senior Housing and Chief Investment Officer | $4,334,767 |
| Carey S. Roberts | Executive Vice President, General Counsel and Ethics & Compliance Officer | $3,617,490 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman of the Board and CEO | $12,628,714 |
| J. Justin Hutchens | EVP, Senior Housing | $5,606,804 |
| Robert Probst | EVP and Chief Financial Officer | $4,833,831 |
| John D. Cobb | EVP and Chief Investment Officer | $4,723,465 |
| Peter Bulgarelli | EVP, Office and President & CEO, Lillibridge Healthcare Services, Inc. | $3,120,317 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman of the Board and CEO | $11,348,335 |
| John D. Cobb | EVP and Chief Investment Officer | $4,942,716 |
| Robert Probst | EVP and Chief Financial Officer | $4,893,277 |
| T. Richard Riney | Former EVP, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer The amounts shown in the Stock Awards column for 2019 reflect the full grant date fair value (“GDFV”) of the 2019 pRSUs and the 2019 time-based RSUs, calculated pursuant to FASB guidance relating to fair value provisions for share-based payments. See Note 12 of the Notes to Consolidated Financial Statements included in the 2019 Form 10-K for a discussion of the assumptions used in calculating GDFV. For further information on these awards, see the 2019 Grants of Plan-Based Awards Table and 2019 Outstanding Equity Awards at Fiscal Year-End Table in this Proxy Statement. These grant date award values, including the maximum potential value of pRSUs as of the grant date, are shown below. | $3,852,003 |
| Peter Bulgarelli | EVP, Office; President and CEO, Lillibridge Healthcare Services, Inc. | $2,669,809 |
| Carey S. Roberts | EVP, General Counsel and Ethics & Compliance Officer | — |
| J. Justin Hutchens | EVP, Senior Housing, North America | — |
| Justin Hutchens | — | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman of the Board and CEO | $13,116,202 |
| Robert Probst | EVP and Chief Financial Officer | $4,995,601 |
| John D. Cobb | EVP and Chief Investment Officer | $4,990,353 |
| T. Richard Riney | Former EVP, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer The amounts shown in the Stock Awards column for 2019 reflect the full grant date fair value (“GDFV”) of the 2019 pRSUs and the 2019 time-based RSUs, calculated pursuant to FASB guidance relating to fair value provisions for share-based payments. See Note 12 of the Notes to Consolidated Financial Statements included in the 2019 Form 10-K for a discussion of the assumptions used in calculating GDFV. For further information on these awards, see the 2019 Grants of Plan-Based Awards Table and 2019 Outstanding Equity Awards at Fiscal Year-End Table in this Proxy Statement. These grant date award values, including the maximum potential value of pRSUs as of the grant date, are shown below. | $3,962,434 |
| Peter Bulgarelli | EVP, Office; President and CEO, Lillibridge Healthcare Services, Inc. | $2,065,320 |
| Justin Hutchens | — | — |
| J. Justin Hutchens | EVP, Senior Housing, North America | — |
| Carey S. Roberts | EVP, General Counsel and Ethics & Compliance Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Debra Cafaro | Chairman of the Board and CEO | $25,254,607 |
| Robert Probst | EVP and Chief Financial Officer | $8,604,297 |
| John D. Cobb | EVP and Chief Investment Officer | $8,359,311 |
| T. Richard Riney | Former EVP, Chief Administrative Officer, General Counsel and Ethics and Compliance Officer The amounts shown in the Stock Awards column for 2019 reflect the full grant date fair value (“GDFV”) of the 2019 pRSUs and the 2019 time-based RSUs, calculated pursuant to FASB guidance relating to fair value provisions for share-based payments. See Note 12 of the Notes to Consolidated Financial Statements included in the 2019 Form 10-K for a discussion of the assumptions used in calculating GDFV. For further information on these awards, see the 2019 Grants of Plan-Based Awards Table and 2019 Outstanding Equity Awards at Fiscal Year-End Table in this Proxy Statement. These grant date award values, including the maximum potential value of pRSUs as of the grant date, are shown below. | $7,120,745 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Laurida Sayed | Senior Vice President, Chief Accounting Officer and Controller | Appointed | 2026-09-15 |
| Carey S. Roberts | Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary | Resigned | 2026-06-15 |
| Peter J. Bulgarelli | Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, In | Retired | 2026-05-15 |
|
Gregory R. Liebbe
“Mr. Liebbe’s decision to resign is not the result of any disagreement with the Company, including with respect to any matter relating to the Company’s accounting practices or financial reporting.”
|
Senior Vice President, Chief Accounting Officer and Controller | Resigned | 2026-02-20 |
| Peter J. Bulgarelli | Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, In | Retired | 2025-11-17 |
| Theodore Bigman | Board of Directors | Appointed | 2024-03-04 |
| Joe V. Rodriguez, Jr. | member of the Board of Directors | Appointed | 2024-03-04 |
| Theodore R. Bigman | member of the Board of Directors | Appointed | 2024-03-04 |
| James D. ("Denny") Shelton | Lead Independent Director | Retired | 2024-03-04 |
| J. Justin Hutchens | Chief Investment Officer | Appointed | 2023-01-25 |
| Sumit Roy | independent director | Appointed | 2022-09-12 |
Leadership
- Debra Cafaro CEO
- Peter Bulgarelli CEO
- Matthew J. Lustig Independent Chairman
- Robert Probst CFO
- J. Justin Hutchens CIO
- John D. Cobb CIO
- Kevin M. Bohl General Counsel
- T. Richard Riney General Counsel
- Laurida Sayed Chief Accounting Officer
- Joe V. Rodriguez, Jr. Board Member
- Marguerite M. Nader Board Member
- Maurice Smith Board Member
- Melody C. Barnes Independent Board Member
- Michael J. Embler Board Member
- Sumit Roy Board Member
- Theodore Bigman Board Member
- Theodore R. Bigman Board Member
Key facts
CIK
740260
CUSIP
92276F100
13F (30d)
922 filings
856 filers
Visit website
Investor relations